LncRNA ROR is Involved in Cerebral Hypoxia/reoxygenation-induced Injury in PC12 Cells Via Regulating MiR-135a-5p/ROCK1/2
Overview
Authors
Affiliations
Ischemic stroke is a common cerebrovascular disease with high morbidity, disability and mortality. LncRNAs were involved in ischemia/reperfusion injury. The present study aims to investigate whether lncRNA ROR can promote the cerebral hypoxia/reoxygenation (H/R) injury in vitro, a cellular model of cerebral ischemia/reperfusion injury, through inhibiting the expression of miR-135a-5p or upregulating the expression of ROCK1 and ROCK2. Reverse transcription-quantitative polymerase chain reaction (RT-qPCR) was used to detect the lncRNA ROR expression in PC12 cells induced by H/R and verify the transfection effect. ROS, LDH, SOD and MDA levels were detected by respective kits. CCK-8 assay and flow cytometry analysis respectively detected the cell viability and cell apoptosis. Western blot analysis was to analyze the expression of apoptosis-related proteins (Bcl-2, Bax and cleaved caspase3). Immunofluorescent staining detected the ROCK1/2 expression. As a result, lncRNA ROR expression was increased in the PC12 cells induced by H/R. LncRNA ROR overexpression could aggravate injury of PC12 cells induced by H/R. And, lncRNA ROR overexpression could decrease viability and promote apoptosis of PC12 cells induced by H/R. In addition, miR-135a-5p was demonstrated to be a target of lncRNA ROR and lncRNA ROR improved H/R injury in PC12 cells by up-regulating the expression of miR-135a-5p via down-regulating ROCK1/2 expression. In conclusion, this study indicated that lncRNA ROR could promote the cerebral H/R injury by inhibiting the expression of miR-135a-5p or upregulating the expression of ROCK1/2. And, miR-135a-5p overexpression could improve the cerebral H/R injury by inhibiting the expression of ROCK1/2.
LncRNAs Orchestrating Neuroinflammation: A Comprehensive Review.
Esmaeili A, Yazdanpanah N, Rezaei N Cell Mol Neurobiol. 2025; 45(1):21.
PMID: 40056236 PMC: 11890384. DOI: 10.1007/s10571-025-01538-0.
Lai G, Shen J, Hu Y, Yang F, Zhang C, Le D Biochem Genet. 2023; 62(5):3586-3604.
PMID: 38157079 DOI: 10.1007/s10528-023-10587-3.
Fang F, Sheng J, Guo Y, Wen J, Chen Z Pharmaceuticals (Basel). 2023; 16(2).
PMID: 37259366 PMC: 9966024. DOI: 10.3390/ph16020218.
miR-135a-5p Suppresses TBK1 and Activates NRF2/TXNIP Antioxidant Pathway in LPS-Driven ALI in Mice.
Zou G, Zeng Y, Wang Y, Luo Y Comput Math Methods Med. 2022; 2022:9088727.
PMID: 35912153 PMC: 9329002. DOI: 10.1155/2022/9088727.
An update on the functional roles of long non‑coding RNAs in ischemic injury (Review).
Cao Y, Liu J, Lu Q, Huang K, Yang B, Reilly J Int J Mol Med. 2022; 50(1).
PMID: 35593308 PMC: 9170192. DOI: 10.3892/ijmm.2022.5147.